|
|
|
Volumn 59, Issue 2, 1999, Pages 273-277
|
|
Hepatitis C: Who should we be treating?
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INTERFERON;
RIBAVIRIN;
ACTIVE IMMUNIZATION;
ANEMIA;
BLOOD TRANSFUSION;
COST EFFECTIVENESS ANALYSIS;
DRUG EFFICACY;
EDITORIAL;
FATIGUE;
HEPATITIS C;
HIGH RISK POPULATION;
HUMAN;
INFECTION RISK;
PREVALENCE;
SCREENING TEST;
SERODIAGNOSIS;
THROMBOCYTOPENIA;
THYROID DISEASE;
TREATMENT PLANNING;
UNITED STATES;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTIVIRAL AGENTS;
FEMALE;
HEPATITIS C;
HUMANS;
INTERFERONS;
MALE;
PRACTICE GUIDELINES;
RISK FACTORS;
|
|
EID: 0033555519
PISSN: 0002838X
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (1)
|
|
References (10)
|
